The ability of the Pfizer/BioNTech mRNA vaccine to prevent infections and prevent symptomatic COVID-19 has dropped to 64 percent, the Israeli government announced late Monday. There was also a smaller drop in the vaccine’s efficacy in preventing hospitalizations and more serious illness.
The decline in effectivity was observed amid the spread of the Delta variant of the CCP (Chinese Communist Party) virus in the country.
